Business
Yulong to Issue the Worlds’ First Biotech Securitized Token Offering
Yulong to Issue the Worlds’ First Biotech Securitized Token Offering.
About this update from Yulong Eco-materials Limited
[{"type":"text","content":"CHEYENNE, WY / ACCESSWIRE / September 21, 2020 / Yulong Eco-Materials Limited / EV Biologics, Inc. (OTC:YECO) today announced that it intends to issue a Securitized Token Offering "STO" to raise funding for research and development - a world's first.Security Token Offering (STO)YECO/EV Biologics is preparing to launch the first ever Securitized Token for cell-based therapy/biological drug development. This move will revolutionize financing for drug development and represents an extraordinary validation of the Security Token Offering capitalization model.This token will be via a SEC registered security to be issued by EV Biologics on an Ethereum-based financial blockchain intended to fund the development of the first extracellular vesicle (EV) based biological drug for the treatment of acute lung injury "ALI". ALI is the core pathophysiologic (the abnormal function of the body's processes associated with disease or injury) process which leads to widely known and potentially fatal diseases including COVID-19 and its aftermath, influenza and acute respiratory distress syndrome. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have demonstrated multiple intrinsic biological properties that conferred therapeutic benefits in preclinical studies.THE OBJECTIVES of this security token offering (STO) are a complete closed bioprocessing system implementation, disease-specific EV optimization, completion of clinical trials and FDA Biologics License Approval (BLA) for this EV biopharmaceutical.The value proposition of the ALI token lies in the ownership and profit-sharing from the distribution and sale of the EV drug upon FDA approval. What this means is that the individual Security Token owner will actually own the Intellectual Property (IP), the Intellectual Technology (IT) and the revenue stream from sales or licensing at a direct ratio of the revenue stream defined by the number of ALI Tokens owned.Acute Lung Injury is the central mechanism contributing to the worldwide tragedy that is affecting millions of people, and for which there is no effective drug currently available. Also commonly caused by trauma, sepsis, pneumonia and drug toxicity, ALI is initiated by an inflammatory process that damages the delicate barrier that separates the air spaces of the lungs from the circulation. This inflamm...